Altered Tissue and Plasma Levels of Fibroblast Activation Protein-α (FAP) in Renal Tumours.
Ontology highlight
ABSTRACT: (1) Background: Renal cell carcinoma (RCC) is a heterogeneous and complex disease with only partial response to therapy, high incidence of metastasis and recurrences, and scarce reliable biomarkers indicative of progression and survival. Cancer-associated fibroblasts (CAFs) play an important role supporting and promoting renal cancer progression. (2) Methods: In this study, we analysed fibroblast activation protein-α (FAP) immunohistochemical expression and its soluble isoform (sFAP) in tumour tissues and plasma from 128 patients with renal tumours. (3) Results: FAP is expressed in the cell surface of CAFs of the tumour centre and infiltrating front from clear cell renal cell carcinomas (CCRCC, n = 89), papillary renal cell carcinomas (PRCC, n = 21), and chromophobe renal cell carcinomas (
SUBMITTER: Solano-Iturri JD
PROVIDER: S-EPMC7696212 | biostudies-literature | 2020 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA